Summary
- Current Price
- As of today, TCRX price is $0.97, down -0.96% in the most recent trading session on
- Current Price All-Time High
- TCRX price is currently -93.40% below its historical high of $14.71 set on
- Market Cap
- TCRX current market cap is $63M, down -35.95% year-over-year
- PE Ratio
- TCRX PE ratio is unknown
- Revenue
- TCRX current annual revenue is $10.33M, up +266.65% year-over-year
- Next Earnings
- As of today, the next earnings release for TCRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | TScan Therapeutics, Inc. |
| Ticker | NASDAQ: TCRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tscan.com |
| Employees | 200 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.97 | ||
| Price, 1D Change | -0.96% | |
| $63M | ||
| - | ||
| - | ||
| 2.48 | ||
| $10M | ||
| Revenue, 1Y Change | +266.65% | |
| -$1.00 | ||
| EPS, 1Y Change | +12.17% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.00 | ||
| EPS Estimate | N/A | -$0.84 |
| EPS Est. Change | N/A | +15.74% |
| $10.33M | ||
| Revenue Estimate | N/A | $7.56M |
| Revenue Est. Change | N/A | -26.80% |
| $0.97 | ||
| Price Target | - | $6.00 |
| Price Tgt. Change | - | +518.17% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.12 | -$1.14 | -1.51% | |
| -$1.24 | -$1.00 | +19.62% | |
| -$0.84 | N/A | +15.74% | |
| -$0.89 | N/A | +11.24% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.60M | $2.82M | -21.79% | |
| $11.15M | $10.33M | -7.44% | |
| $7.56M | N/A | -26.80% | |
| $7.81M | N/A | -24.39% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -44.54% | ||
| -65.46% | ||
| -35.95% | ||
| -52.49% | ||
| +266.65% | ||
| -23.72% | ||
| +12.17% | ||
| +63.69% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.97 | ||
| $1.32 | ||
| $1.11 | ||
| $1.36 | ||
| $1.10 | ||
| -$0.03 | ||
| 2.48 | ||
| $0.08 | ||
| 38.48 | ||
| 52.57% | ||
| 85.60% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $10.33M | ||
| -$1.00 | ||
| $7.46M | ||
| 72.24% | ||
| -$135.81M | ||
| -1,315.38% | ||
| -$129.77M | ||
| -1,256.81% | ||
| -$132.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.76 | ||
| 8.41 | ||
| 8.41 | ||
| - | ||
| 3 | ||
| -3.69 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.94 | ||
| 0.65 | ||
| -0.22 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $123.12M | ||
| $152.41M | ||
| $244.56M | ||
| $157.21M | ||
| $121.44M | ||
| $18.70M | ||
| $94.14M | ||
| $7.17M | ||
| $1.24M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $140.09M | ||
| $143.27M | ||
| $2.87M | ||
| $0.00 | ||
| $2.87M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$135.92M | ||
| $109.37M | ||
| $264.00K | ||
| $4.41M | ||
| -$140.33M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with TCRX
FAQ
What is the ticker symbol for TScan Therapeutics, Inc.?
The ticker symbol for TScan Therapeutics, Inc. is NASDAQ:TCRX
Does TScan Therapeutics, Inc. pay dividends?
No, TScan Therapeutics, Inc. does not pay dividends
What sector is TScan Therapeutics, Inc. in?
TScan Therapeutics, Inc. is in the Healthcare sector
What industry is TScan Therapeutics, Inc. in?
TScan Therapeutics, Inc. is in the Biotechnology industry
What country is TScan Therapeutics, Inc. based in?
TScan Therapeutics, Inc. is headquartered in United States
When did TScan Therapeutics, Inc. go public?
TScan Therapeutics, Inc. initial public offering (IPO) was on July 16, 2021
Is TScan Therapeutics, Inc. in the S&P 500?
No, TScan Therapeutics, Inc. is not included in the S&P 500 index
Is TScan Therapeutics, Inc. in the NASDAQ 100?
No, TScan Therapeutics, Inc. is not included in the NASDAQ 100 index
Is TScan Therapeutics, Inc. in the Dow Jones?
No, TScan Therapeutics, Inc. is not included in the Dow Jones index
When was TScan Therapeutics, Inc. last earnings report?
TScan Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does TScan Therapeutics, Inc. report earnings?
The date for TScan Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- TCRX Official Website www.tscan.com
- TCRX Profile on Yahoo Finance finance.yahoo.com/quote/TCRX
- TCRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tcrx